INTRODUCTION
Nasal polyposis is a complex inflammatory disease with a predominance of eosinophils infiltration, regulated by T lymphocyte subsets and represents a late stage of long-lasting inflammation of the sinonasal mucosa 1, 2 . The increased inflammatory cells infiltration and persistent inflammation can lead to structural changes of the respiratory epithelium, resulting a unique remodelling process 3 . Various hypotheses regarding the underlying mechanism of nasal polyposis have been put forward, including chronic infection, nasal epithelial disruptions, allergies, inflammatory-bioelectric theory, aerodynamic factors, immune system malfunctions. Despite remarkable scientific progress, the pathogenesis of nasal polyposis has not yet been fully elucidated 4 . The chronic inflammatory specific feature, tendency to recurrence, troublesome symptoms, lack of satisfying treatment suggest that this entity remains a serious health problem worldwide, with significant socioeconomic consequences.
Research made in the last decade has documented an impairment in the regulation of a wide range of inflammatory markers and cell types in patients with nasal polyposis 4, 5 .
Histologically, nasal polyposis is typically characterized by epithelial damage, thickened basement membrane, intense edematous stroma with albumin deposition, formation of pseudocysts, accompanied by the infiltration of inflammatory cells mainly consisting of eosinophils, but also mast cells, macrophages, lymphocytes and neutrophils 6 . Eosinophils are the dominant inflammatory cell population in nasal polyposis and are thought to be the central effector cells responsible for the onset and maintenance of the inflammatory process 7 . Mechanisms underlying the activation, recruitment and survival of eosinophils involve a complex interaction of multiple inflammatory cells and pathways. Increased synthesis and expression of an affluence of cytokines ((IL-1, IL-3, IL-5, IL-6, IFNα) and chemokines (IL-8, eotaxin, RANTES) play a crucial role in eosinophils survival and activation, mediating these processes 7, 8 . Another important class of inflammatory mediators is the adhesion molecules (ICAM-1, VCAM-1), which are responsible for the migration of inflammatory cells to the damaged tissue. Recent studies offer important and needful information on the pattern of local inflammation and its related pathologic mechanism 8 . The following material summarizes prior and current knowledge concerning the involvement of inflammatory cells in nasal polyposis.
INFLUENCE OF CHEMICAL MEDIATORS ON EOSINOPHILIC INFLAMMATION
In nasal polyposis, for reasons not fully clarified, there is an astonishing influx of inflammatory cells, predominantly eosinophils, into the stroma, which activate a positive feedback loop by recruiting additional eosinophils. Eosinophil tissue accumulation stimulates other inflammatory cells inducing an amplification of the inflammatory process, thus maintaining the vicious cycle 9 .
In an attempt to better understand the inflammatory process of nasal polyposis, it is helpful to define more clearly the mechanisms underlying the activation, migration and maintenance of eosinophils 10 . Eosinophils play a dominant role in the development of nasal polyposis, being the main infiltrating inflammatory cells. Eosinophils are recruited from the peripheral blood circulation by chemotactic factors and activated into inflamed tissues, in response to inflammatory-derived mediators 10, 11 . At the site of inflammation, they perform their end-phase effector function through differential secretion of proinflammatory mediators and cytotoxic proteins. They produce a broad array of highly toxic preformed granule proteins (major basic protein-MBP, eosinophil cationic protein-ECP, eosinophil peroxidase-EPO), different cytokines (IL-1, IL-3, IL-4, IL-5, IL-10, IL-12, GM-CSF, INFα, TNFα), chemokines (IL-8, eotaxin, RANTES), with different target activities. These mediators have pro-inflammatory effects in the upregulation of adhesion molecules (ICAM-1, VCAM-1), modulation of cellular trafficking and induction tissue damage 11, 12 .
CYTOKINES
Proinflammatory cytokines represent key signalling molecules, involved in processes such as chemotaxis, control of cellular proliferation, cell activation, differentiations and function of many cells participating in the inflammatory process.
Many studies that have focused on the cytokines responsible for eosinophils function have shown that these include interleukins such as IL-1, IL-3, IL-4, IL-5, IL-10, GM-CSF, TNFα, even if each of them is implicated in a different manner 12 . Of great importance are IL-3, IL-5 and GM-CSF that induce eosinophilic effector function and survival of eosinophils and also stimulate eosinophils to express a variety of receptors for cytokines 12, 13 . IL-3 is a cytokine which promoting the development and functional activity of various haematopoietic cell types, including eosinophils.
GM-CSF is an important haematopoietic growth factor which stimulates proliferation, activation and differentiation of macrophages, neutrophils and eosinophils 14 .
IL-5 is a cytokine that stimulates growth and differentiation of the eosinophil lineage in the bone marrow, mediates the activation and selective migration of eosinophils from the peripheral circulation into the tissue, increases the vitality of eosinophils by impeding their apoptosis 14, 15 . IL-3, IL-5 and GM-CSF share similar functions when they act on the same cells. In vitro studies have assessed the ability of IL-3, IL-5 and GM-CSF to improve eosinophil survival. One of their most important effects is to prolong eosinophil life span by deferring the onset of apoptosis 16, 17 . Of these, IL-5 has been recognized as the most specific cytokine to eosinophils and represents the main key driver regulator of eosinopoiesis. Interleukin 5 is produced by Th 2 cells, although it can also be synthesized and released by eosinophils, stirring an autocrine inflammatory process that is able to maintain the persistent eosinophilia. The role of IL-5 in the pathogenesis of nasal polyposis is supported by several lines of experimental evidence. Elevated levels of IL-5 found in nasal polyposis highlight the importance of this cytokine in the pathogenesis of this disease 17 . Fan et al. in their study suggest that IL-5 secretion induced by Th 2 cell and autosecretion of IL-5 from activated eosinophils may be the cause reasons for the onset and maintenance of eosinophil inflammation in the nasal polyp tissue 18 . Another study led by Hirschberg et al. revealed that IL-5 is a pivotal factor involved in the eosinophil recruitment and activation 19 . The production and activity of eosinophils are significantly directed by IL-5 via the IL-5 receptor (α chain), specifically expressed on their surface and precursors, pointing out its role in the inflammatory process 20 . Evaluation of the apoptotic behaviour of eosinophils through in vitro studies demonstrates that IL-5 decreases the rate of eosinophil programmed cell death 19, 20 . According to Jankowski et al., eosinophils, even at lower levels, play an important role in the development of polyps 21 . Ex vivo studies have shown that the eosinophil life span was reduced by incubation with anti-IL-5 monoclonal antibodies, indicating the significant role of IL-5 in the regulation of eosinophil survival.
Current research studies have provided evidence suggesting that staphylococcal super antigens can induce the synthesis of IL-5 and promote eosinophil activation.
Aside from its effects on eosinophils, IL-5 enhances the expression of the adhesion molecules VCAM-1and ICAM-1. In addition to activating eosinophils, IL-3 also downregulates the chemokine receptor CCR3 on the surface of eosinophils. The two cytokines IL-3 and IL-5 work in tandem to induce eosinophil differentiation from progenitor cells 22 . Dellacono et al. were able to establish the existence of a positive correlation between the GM-CSF-mRA levels and the number of eosinophils in nasal polyps 23 . IL-5 in combination with IL-1β and TNFα increase transendothelial migration of eosinophils. Although it has been demonstrated that TNFα and IL-1 enhance eosinophil life span in vitro, it has also been investigated their ability to modulate the expression of several cell adhesion molecules on endothelial cells. IL-1β has been proposed to play a crucial role in the pathogenesis of nasal polyps 24, 25 . Through its action this cytokine, it can increase transendothelial migration of eosinophils. In the study by Saji et al., investigators noted that eosinophil infiltration was induced by fibroblasts through the action of IL-1β 26 . The concentrations of some other proinflammatory cytokines, such as IL-6, IL-9, IL-13, are higher in patients with nasal polyposis. In vitro studies developed over the last years have pointed that IL-13 promotes the chemotaxis and prolongs the survival of eosinophils.
Despite the fact that there is a large array of cytokines that affect the activity of eosinophils, these findings collectively suggest that IL-5 is one of the most influential inflammatory mediators for eosinophils activity 27 .
CHEMOKINES
As cytokines, chemokines became the target of intense debate regarding their importance in coordinating the function and trafficking of eosinophils. Increased expression and production of chemokines found in nasal polyposis developed an intense interest regarding their mechanism of action and binding. Various functions have been assigned to chemokines, including proinflammatory activities such as chemotaxis, degranulation, functions which are mediated by receptors. Signals elicited through chemokines receptors play an important role in the inflammatory process of nasal polyposis. Experimental observations suggest that there is an interdependence between the number of eosinophils and the tissue concentration of the individual chemokines 28, 29 . Eosinophils generate a large number of chemokines, including MIP, MCP RANTES, eotaxin, which represent major regulators of local inflammatory response 30 . Eotaxin and RANTES are two factors of particular significance with chemotactic and activating effects in eosinophils 31 . Eotaxin is a potent stimulus for eosinophils, inducing eosinophil migration and accumulation via high affinity to the chemokine receptor 3(CCR3) 32 . Recent research indicates that all members of the Eotaxin family (1, 2, 3) play key roles in the inflammatory process of nasal polyposis. Significantly increased amounts of Eotaxin 1, Eotaxin 2, Eotaxin 3 were present in the polyp tissue, when compared with the control tissue. Various authors have demonstrated through in vitro and in vivo experiments, the specific chemotactic potency of all eotaxins. Eotaxin is a specific chemoattractant for eosinophils. It is produced by cytokine-stimulated epithelial and endothelial cells as well as IL-3-stimulated eosinophils 32, 33 . Eotaxin has been shown to induce eosinophil migration in vivo. Multiple findings suggest that nasal polyps are a rich source of eotaxin 34 . Eotaxin 1, along with eosinophil survival factor IL-5, was found to be implicated in eosinophil recruitment in nasal polyposis. Eotaxin may favour eosinophil accumulation to the nasal mucosa endothelial cells through its effect on the selective expression of endothelial adhesion molecules. Hence, eotaxin has multifaceted effects on eosinophils and is likely to play a key role in determining the increase of tissue eosinophilia 34, 35 . In addition to eotaxin, another important chemokine strongly related to nasal polyposis is RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted). RANTES is a chemokine with chemotactic activity mainly on eosinophils and T lymphocytes. High levels of RANTES lead to increased tissue eosinophilia and induce the recruitment and activation of eosinophils. Previous studies have demonstrated that RANTES has been shown to be a potent mediator of eosinophil chemotaxis 36 . RANTES is an important recruiter and activator of eosinophils and its relationship to nasal polyposis has been analyzed in different manners 37, 38 . Comparing polyps with control specimens, Lane et al. noted higher expression of RANTES in nasal polyposis 39 . Apart from high amounts of RANTES found in nasal polyps specimens, Saji et al. have also demonstrated that nasal polyp fibroblasts play a major role in the mechanism of eosinophil recruitment through RANTES production 40 .
Another important chemokine implicated in nasal polyposis pathogenesis is IL-8. This chemokine represents a potent chemoattractant for neutrophils, but also has chemotactic effect on eosinophils, attracting them to the site of inflammation 41 . Data regarding its role in the development of nasal polyposis report that IL-8 is an important chemokine with chemotactic activity for eosinophils. According to most recent studies, IL-8 is an important chemokine in the pathogenesis of nasal polyposis, as demonstrated by elevated levels detected in tissue samples. It has been demonstrated that IL-8 delivers signals that lead to selective influx of eosinophils 41, 42 .
CELL ADHESION MOLECULES
An assessment of the unique and complex mechanism responsible for mobilization of eosinophils into the airways lumen has established that this includes also a range of both adhesion molecules expressed on eosinophils and endothelial cells, such as ICAM-1, VCAM-1, selectins (E-selectin, P-selectin), integrins 43 . It has been suggested that adhesion molecules play a significant role in the pathogenesis of nasal polyposis, although this class of inflammatory mediators needs to be better studied 44 . In biopsies taken from patients with nasal polyposis, increased levels of ICAM-1, VCAM-1, E-selectin have been noticed 45 .
In vitro studies have found that VCAM-1 is an important and relatively selective chemoattractant for eosinophils, mediating recruitment, sequestration and transendothelial migration of these cells 46 . The research of several groups has proved that increased levels of VCAM-1 detected in patients with nasal polyposis were correlated with the presence of eosinophils, leading to the assumption that eosinophil recruitment is, in part, mediated by VCAM-1 47 . In addition to increased levels of VCAM-1, Beck et al in their findings have found a positive correlation between VCAM-1 and the number of eosinophils 48 . Moreover, ICAM-1 has been revealed to be expressed in vascular endothelial cells and implicated in the migration of eosinophils from blood vessels to tissues and eosinophil infiltration. Thus, ICAM-1 plays a major role in promoting proinflammatory intercellular response; its role in nasal polyposis has not been elucidated despite its elevated levels of expression 49 .
Aside from VCAM-1, another adhesion molecule able to stimulate the recruitment of eosinophils in nasal polyposis is P-selectin 50 .
CONCLUSIONS
Although nasal polyposis is considered a multifactorial disease with still debated pathogenesis, numerous studies have demonstrated that eosinophil infiltration, regulated by T lymphocyte subsets, is the main key feature. Nasal polyposis remains a major health problem worldwide, which creates a serious financial and psychosocial impact.
A growing body of evidence demonstrated that nasal polyposis is a complex interplay of numerous cytokines, chemokines, adhesion cells and receptors. Investigation of individual inflammatory mediators is essential for enhancing the understanding of their precise contribution to the initiation and maintenance of chronic inflammation in this disease.
The present studies definitely provide significant information to further expand the research in this field.
Additional research is needed to further explain and define the complexity of the mechanisms responsible for chronic inflammatory response in nasal polyposis. Given the inflammatory condition of nasal polyposis, elucidation of the underlying inflammatory patterns is indispensable for developing new therapeutic strategies.
